跳至主要内容
临床试验/KCT0007484
KCT0007484尚未招募未知

Discrimination of malignancy in CT detected lung nodules by Cancer SignatureEnsemble (CSE) of peripheral blood cfDNA

Chonnam National University Hospital Hwasun Hospital0 个研究点目标入组 330 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
330

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
50(Year) 至 80(Year)(—)
性别
All

入选标准

  • 1. ECOG performance status 0 or 1
  • 2. Age: 50-80 years old
  • 3. Current smokers over 20 pack years or past smokers with less than 15 years of smoking cessation
  • 4. Biopsy is planned for lung nodules and either A or B below
  • A. A person who has a lung nodule found on chest CT, Lung-RADS category 4B or 4X, and TNM stage (8th edition) clinical stage IA lung cancer.
  • B. TNM stage (8th edition) clinical stage III~IV lung cancer patients.
  • 5. Sign the consent form to participate in the study

排除标准

  • 1. ECOG performance status 2, 3, or 4
  • 2. Age: under 50, or over 80
  • 3. Cancer diagnosis and active treatment within the past 5 years
  • 4. Subjects who do not agree to participate in the study

研究者

发起方
Chonnam National University Hospital Hwasun Hospital

相似试验

Discrimination of malignancy in CT detected lung... | 临床试验